Study Summary
This trial is for subjects with multiple myeloma who are eligible for high-dose therapy and autologous stem cell transplantation.
Eligible Conditions
- Multiple Myeloma
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: 100 days
100 days
Therapeutic procedure
Time to neutrophil recovery
24 hours
Number of participants with a treatment-limiting toxicity
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Experimental Arm:single
1 of 1
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Hyperbaric oxygen · No Placebo Group · Phase < 1
Experimental Arm:single
Drug
Experimental Group · 1 Intervention: Hyperbaric oxygen · Intervention Types: DrugTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen
2020
Completed Phase 2
~220
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 100 days
Who is running the clinical trial?
University of RochesterLead Sponsor
791 Previous Clinical Trials
501,734 Total Patients Enrolled
11 Trials studying Multiple Myeloma
311 Patients Enrolled for Multiple Myeloma
Omar Aljitawi, MMBSPrincipal InvestigatorUniversity of Rochester
Eligibility Criteria
Age 18 - 75 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments